Ginger.io announced a new research collaboration with UC San Francisco, Partners HealthCare (Massachusetts General Hospital, Brigham and Women’s Hospital, and McLean Hospital), Duke University, UC Davis and University of Nebraska Medical Center.
Using a special app installed on patients’ smartphones, the company will be able to passively collect data to identify patterns in patients’ behavior and mental state that may impact their health and well-being. Additionally, the application will also allow doctor to reach out when patients need support.
Each institution have different plan of deploying Ginger.io’s platform. Some are using it for behavioral health application in a research setting to measure digital interventions in patients with major depressive disorder. Others want to conduct research on how to reduce hospital readmissions for patients with psychiatric conditions, including schizophrenia and bipolar disorder. And there are those using Ginger.io technology in diverse disease areas to more effectively connect the dots between patient behaviors and specific health outcomes.
Finally, UCSF wants to help patients suffering from heart disease, multiple sclerosis and post-operative recovery. They will rely on Ginger.io to assist cardiologists in detecting early-warning signals for the development and exacerbation of heart disease.
Ginger.io will be able to passively collect data to identify patterns in patients’ behavior and mental state that may impact their health and well-being.“Our partners are either deploying Ginger.io’s existing core behavioral health (i.e., mental health) programs in new and exciting ways, or they are using the Ginger.io platform on new conditions like heart disease and chronic pain,” said Dr. Ilan Elson, Head of Research and Development at Ginger.io.
Ginger.io research partners will publish their results based on findings and insights driven by Ginger.io’s data collection and machine learning analytics engine.